| Page No 1 2 3 |
| Phrase | Consultant | Town | Special Interests |
| development of new biomaterials | *Consultant(s)* | *Towns* | Oral medicine and surgery, development of new biomaterials |
| development of new treatments for psychosis | *Consultant(s)* | *Towns* | Mechanisms underlying psychotic symptoms and psychosis, development of new treatments for psychosis |
| development of novel anti-cancer therapeutic and diagnostic radiopharmaceuticals | *Consultant(s)* | *Towns* | Clinical oncology, radiation oncology, development of novel anti-cancer therapeutic and diagnostic radiopharmaceuticals |
| development of simulation training | *Consultant(s)* | *Towns* | Training and education, development of simulation training, neonatal haemophilia |
| development paediatrics | *Consultant(s)* | *Towns* | Community child health, development paediatrics, neurodisability, autistic spectrum disorder, ADHD |
| device development and evaluation (CE-marking) | *Consultant(s)* | *Towns* | Diagnostic and interventional neuroradiology, design and set up of clinical trials, device development and evaluation (CE-marking), high-fidelity medical simulation, reference site (core laboratory for clinical trials), set up of thrombectomy services |
| disorders of sexual development | *Consultant(s)* | *Towns* | Paediatric endocrinology and diabetes, metabolic bone disease, skeletal dysplasias, disorders of sexual development |
| disorders/differences in sex development in children | *Consultant(s)* | *Towns* | Late endocrine effects of oncological treatment and congenital hyperinsulinism in children, disorders/differences in sex development in children |
| drug development | *Consultant(s)* | *Towns* | Gastrointestinal cancers, melanoma, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, clinical trials, cancer therapeutics, drug development |
| drug development | *Consultant(s)* | *Towns* | Ischaemic heart disease, heart failure, cardiac electrophysiology, pacemaker/ICD - implantable cardioverter defibrillator implantation, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal cancer, melanoma, drug development |
| drug development | *Consultant(s)* | *Towns* | Paediatric neuro-oncology, drug development - childhood cancer, the biology of childhood malignant glioma, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, angiogenesis, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, immunotherapy, targeted therapy, cancer biomarkers, drug development |
| drug development | *Consultant(s)* | *Towns* | Paediatric oncology, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, hepatocellular cancer, immunotherapy, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, drug development, breast cancer, colorectal cancer |
| drug development - childhood cancer | *Consultant(s)* | *Towns* | Paediatric neuro-oncology, drug development - childhood cancer, the biology of childhood malignant glioma, drug development |
| drug discovery/development | *Consultant(s)* | *Towns* | Lung cancer, mesothelioma, pleural disease, drug discovery/development |
| DSD - disorders of sex development | *Consultant(s)* | *Towns* | Paediatric urology, laparoscopy, urogenital sinus anomalies, cloaca, DSD - disorders of sex development, hypospadias |
| DSD - disorders of sex development | *Consultant(s)* | *Towns* | Diabetes and obesity, DSD - disorders of sex development, hormone aspects of gynaecological problems |
| DSD - disorders of sex development | *Consultant(s)* | *Towns* | Paediatric endocrinology, growth, puberty, bone growth, thyroid, pituitary, DSD - disorders of sex development |
| DSD - disorders of sex development | *Consultant(s)* | *Towns* | Hypospadias, paediatric urology, DSD - disorders of sex development, patient safety |
| early drug development | *Consultant(s)* | *Towns* | Medical oncology, genito-urinary oncology, translational oncology, early drug development |
| factors affecting growth and development | *Consultant(s)* | *Towns* | Gynaecological endocrinology, menorrhagia, menopause, infertility, assisted conception and related surgery, storage of reproductive function prior to chemotherapy and radiotherapy, factors affecting growth and development, implantation of embryos, benign gynaecology |
| foreskin development | *Consultant(s)* | *Towns* | Paediatric A&E, paediatric oncology, nutrition in surgical patients, foreskin development, foreskin problems, undescended testes, Currarino trial |
| gastrointestinal immunity and infections and vaccine development | *Consultant(s)* | *Towns* | IBD - inflammatory bowel disease, Crohn's disease, ulcerative colitis, gastrointestinal immunity and infections and vaccine development, nutrition and irritable bowel syndrome - IBS, dyspepsia and reflux disease, feeding tube placement and nutrition, endoscopic ultrasound and laser therapy |
| growth and development | *Consultant(s)* | *Towns* | Paediatric endocrinology, neuroendocrine and late effects of childhood malignancy, adolescence to 21yrs, growth and development, reproductive maturity, Turner's syndrome, congenital adrenal hyperplasia, short stature, paediatric endocrine oncology, pituitary tumours in childhood |
| guideline development | *Consultant(s)* | *Towns* | Paediatric rheumatology, juvenile idiopathic arthritis, guideline development, chronic recurrent multifocal osteomyelitis - CRMO/CNO, uveitis associated with juvenile idiopathic arthritis |
| guideline development | *Consultant(s)* | *Towns* | Community paediatrics, guideline development, evidence based medicine, evidence into practice translation/health services research, participatory research, public engagement, science communication |
| healthcare pathway development | *Consultant(s)* | *Towns* | Adult ADHD, autism, healthcare pathway development, depressive disorder, schizophrenia |
| imaging in drug development | *Consultant(s)* | *Towns* | Diagnostic radiology, MRI, CT, oncology, functional MRI, imaging in drug development, prostate MRI |
| International development | *Consultant(s)* | *Towns* | International development, adult psychiatry, transcultural psychiatry |
| leadership development | *Consultant(s)* | *Towns* | Echocardiography, valve disease, transoesophageal echo, leadership development |
| lung development | *Consultant(s)* | *Towns* | Paediatrics, primary ciliary dyskinesia - PCD, paediatric bronchiectasis and wet cough, lung development |
| Lung development | *Consultant(s)* | *Towns* | Lung development, respiratory problems, cardiology, education and training |
| management and service development | *Consultant(s)* | *Towns* | Leadership, management and service development, enhanced care |
| medical lead for research and development | *Consultant(s)* | *Towns* | Old age psychiatry, general adult liaison psychiatry, medical lead for research and development |
| mental health outcome development | *Consultant(s)* | *Towns* | Old age psychiatry, dementia, depression, mental health outcome development, public mental health |
| molecular biomarker development | *Consultant(s)* | *Towns* | Molecular biology in cancer and causes of cancer, facial pain, human papillomavirus, head and neck cancer, bisphosphonate osteonecrosis, molecular biomarker development |
| neonatal development | *Consultant(s)* | *Towns* | Paediatric neonatal medicine, neonatal intensive care, neonatal cardiology, neonatal development, hypoxic ischaemic encephalopathy - HIE |
| neonatal development | *Consultant(s)* | *Towns* | Community child health, early intervention, Down's syndrome, neonatal development, autism spectrum disorders, child protection |
| new drug development in paediatric oncology | *Consultant(s)* | *Towns* | Brain tumours in childhood, liver tumours in childhood, bone and soft tissue tumours in childhood, new drug development in paediatric oncology |
| paediatric development | *Consultant(s)* | *Towns* | Paediatric neurodisability, paediatric development, paediatric neurology |
| paediatric development | *Consultant(s)* | *Towns* | Paediatrics and neonatology, paediatric development, child protection, safeguarding |
| Paediatric oral health and development | *Consultant(s)* | *Towns* | Paediatric oral health and development, dental trauma |
| patient and carer involvement in service development | *Consultant(s)* | *Towns* | ADHD in children with learning disabilities, patient and carer involvement in service development |
| Page No 1 2 3 |
